member sign in

Manuscripts IJBNPA

  • For completed randomized controlled trials, IJBNPA requires the submission of a populated CONSORT checklist and flow diagram. The flow diagram should be included in the main body of the text and the checklist should be provided as an additional file. Both the flow diagram and the checklist should be referenced in the text. Submissions received without these elements will be returned to the authors as incomplete. A Word file of the checklist and flow diagram can be downloaded here. For all intervention components, authors are required to use the TIDieR Checklist, which should be provided as an additional file. The TIDieR Checklist is available to download as a PDF and a Word file. For observational studies, IJBNPA requires the submission of a populated STROBE checklist (http://strobe-statement.org/index.php?id=available-checklists) along with the manuscript. The completed checklist should be provided as an additional file. There is no specific word limit, but articles should be as concise as possible. Articles that exceed 5000 words are rarely published. If an article is accepted for publication, the submitting author will be asked to provide at least one tweet of about 100 characters, together with your (or an institute) Twitter name which will be used to help publicise the paper at the point of publication.

  • Reviews are summaries of recent insights in specific research areas within the scope of IJBNPA. Key aims of reviews are to provide systematic and substantial coverage of mature subjects, evaluations of progress in specified areas, and/or critical assessments of emerging technologies. Cover letters must include the names and emails of at least 4 potential reviewers. These must be from a different institution to the first author and not have published with any member of the writing group in the previous 3 years. Cover letters must contain a rationale for how the manuscript is novel, why it is relevant to the journal, and how the research contributes to the field or advances the evidence base. For systematic reviews and meta-analyses, IJBNPA requires the use of PRISMA guidelines by authors (http://www.prisma-statement.org/). If an article is accepted for publication, the submitting author will be asked to provide at least one tweet of about 100 characters, together with your (or an institute) twitter name which will be used to help publicise the paper at the point of publication. There is no specific word limit, but articles should be as concise as possible. Articles that exceed 5000 words are rarely published.

  • These short, narrowly focused articles of contemporary interest are usually commissioned by the journal. They are not mini-reviews. A commentary generally takes one of two forms: The first form is a discussion of an article that was recently published or that is soon to be published, and that is interesting enough to warrant further comment or explanation. This type of commentary discusses specific issues within a subject area rather than the whole field, explains the implications of the article and puts it in context. Opinions are welcome as long as they are factually based. The second form is more editorial in nature and covers an aspect of an issue that is relevant to the journal's scope. Examples of this type of commentary could be a discussion of the impact of new technology on research and treatment, or a discussion of changes in peer review or grant application procedures and their effect on research. By their nature, the second form of commentary is less frequent. Commentaries are restricted to no more than 1,500 words. A maximum of ten articles may be included in the references.

  • Debates should present an argument that is not essentially based on practical research. If an article is accepted for publication, the submitting author will be asked to provide at least one tweet of about 100 characters, together with your (or an institute) twitter name which will be used to help publicise the paper at the point of publication.

  • Methodologies should present a new experimental or computational method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value. Cover letters must include the names and emails of at least 4 potential reviewers. These must be from a different institution to the first author and not have published with any member of the writing group in the previous 3 years. Cover letters must contain a rationale for how the manuscript is novel, why it is relevant to the journal, and how the research contributes to the field or advances the evidence base. There is no specific word limit, but articles should be as concise as possible. Articles that exceed 5000 words are rarely published. If an article is accepted for publication, the submitting author will be asked to provide at least one tweet of about 100 characters, together with your (or an institute) twitter name which will be used to help publicise the paper at the point of publication.

  • Short papers are suitable for the presentation of research that extends previously published research, including the reporting of additional controls and confirmatory results in other settings, as well as negative results. Authors must clearly acknowledge any work upon which they are building, both published and unpublished.

Article Processing Fee

If you are submitting a manuscript to IJBNPA and the lead or corresponding author is a financial member of ISBNPA at the time of lodgement, then you are entitled to a 20% reduction in the Article Processing Fee. 

To obtain the 20% reduction, you will need to select Option 3A on the Payment options page during the submission process. Here you will need to enter the membership code into the box provided. To obtain the membership code contact: ijbnpa-office@bristol.ac.uk or executivedirector@isbnpa.org